Trial · NCT05475106
Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms
NCT05475106, Early phase 1, Unknown, Instituto de Medicina Regenerativa
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms. Trials, record NCT05475106. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05475106
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms
- NCT number
- NCT05475106
- Status
- Unknown
- Phases
- Early phase 1
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Instituto de Medicina Regenerativa
- Conditions
- Neoplasms
- Interventions
- Neoantigen Peptides
- First posted
- 2022-07-26
- Last updated
- 2024-03-06
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in WBC count | Baseline, 2, 6, 12 months | WBC quantification in blood and comparison at different timepoints |
| Primary | Change from Baseline in RBC count | Baseline, 2, 6, 12 months | RBC quantification in blood and comparison at different timepoints |
| Secondary | Change from Baseline in Calcitonin levels | Baseline, 2, 6, 12 months | Measured in blood, to assess treatment response at different timepoints |
| Secondary | Change from Baseline in CA-125 levels at | Baseline, 2, 6, 12 months | Measured in blood, to assess treatment response at different timepoints |
| Secondary | Change from Baseline in beta-2-microglobulin levels | Baseline, 2, 6, 12 months | Measured in blood and urine, to assess treatment response at different timepoints |
| Secondary | Change from Baseline in sum of diameter of target lesions | Baseline, 2, 6, 12 months | Measured in the longest diameter in the plane of measurement in CT according to RECIST 1.1 criteria |
| Secondary | Change from Baseline in sum of diameter of non-target lesions | Baseline, 2, 6, 12 months | Measured in the longest diameter in the plane of measurement in CT according to RECIST 1.1 criteria |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05475106
GET https://conductscience.org/api/trials/v1/NCT05475106/registered